Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin Boyerinas

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Biomedicines|May 25, 2017
Genetic Modification of T CellsRichard A Morgan, Benjamin Boyerinas
Endocrine-Related Cancer|September 26, 2009
The role of let-7 in cell differentiation and cancerBenjamin Boyerinas, Sun-Mi Park, Annika Hau, et al.
Blood|April 17, 2013
Adhesion to osteopontin in the bone marrow niche regulates lymphoblastic leukemia cell dormancyBenjamin Boyerinas, Maya Zafrir, Ali E Yesilkanal, et al.
Cancer Immunology, Immunotherapy : CII|November 16, 2013
Identification and characterization of agonist epitopes of the MUC1-C oncoproteinCaroline Jochems, Jo A Tucker, Matteo Vergati, et al.
Cancer Immunology Research|May 28, 2015
Antibody-Dependent Cellular Cytotoxicity Activity of a Novel Anti-PD-L1 Antibody Avelumab (MSB0010718C) on Human Tumor CellsBenjamin Boyerinas, Caroline Jochems, Massimo Fantini, et al.
International Journal of Cancer|May 28, 2011
Let-7 modulates acquired resistance of ovarian cancer to Taxanes via IMP-1-mediated stabilization of multidrug resistance 1Benjamin Boyerinas, Sun-Mi Park, Andrea E Murmann, et al.
Cancer Immunology, Immunotherapy : CII|September 5, 2014
Identification and characterization of a cytotoxic T-lymphocyte agonist epitope of brachyury, a transcription factor involved in epithelial to mesenchymal transition and metastasisJo A Tucker, Caroline Jochems, Benjamin Boyerinas, et al.
Cancer Research|April 17, 2008
Identification of let-7-regulated oncofetal genesBenjamin Boyerinas, Sun-Mi Park, Noam Shomron, et al.
Journal for Immunotherapy of Cancer|March 13, 2023
Metabolic reprogramming via an engineered PGC-1α improves human chimeric antigen receptor T-cell therapy against solid tumorsKonstantinos Lontos, Yiyang Wang, Supriya K Joshi, et al.
Molecular Cell|August 3, 2005
Phosphorylation of FADD at serine 194 by CKIalpha regulates its nonapoptotic activitiesElizabeth C Alappat, Christine Feig, Benjamin Boyerinas, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Biomedicines|May 25, 2017
Genetic Modification of T CellsRichard A Morgan, Benjamin Boyerinas
Endocrine-Related Cancer|September 26, 2009
The role of let-7 in cell differentiation and cancerBenjamin Boyerinas, Sun-Mi Park, Annika Hau, et al.
Blood|April 17, 2013
Adhesion to osteopontin in the bone marrow niche regulates lymphoblastic leukemia cell dormancyBenjamin Boyerinas, Maya Zafrir, Ali E Yesilkanal, et al.
Cancer Immunology, Immunotherapy : CII|November 16, 2013
Identification and characterization of agonist epitopes of the MUC1-C oncoproteinCaroline Jochems, Jo A Tucker, Matteo Vergati, et al.
Cancer Immunology Research|May 28, 2015
Antibody-Dependent Cellular Cytotoxicity Activity of a Novel Anti-PD-L1 Antibody Avelumab (MSB0010718C) on Human Tumor CellsBenjamin Boyerinas, Caroline Jochems, Massimo Fantini, et al.
International Journal of Cancer|May 28, 2011
Let-7 modulates acquired resistance of ovarian cancer to Taxanes via IMP-1-mediated stabilization of multidrug resistance 1Benjamin Boyerinas, Sun-Mi Park, Andrea E Murmann, et al.
Cancer Immunology, Immunotherapy : CII|September 5, 2014
Identification and characterization of a cytotoxic T-lymphocyte agonist epitope of brachyury, a transcription factor involved in epithelial to mesenchymal transition and metastasisJo A Tucker, Caroline Jochems, Benjamin Boyerinas, et al.
Cancer Research|April 17, 2008
Identification of let-7-regulated oncofetal genesBenjamin Boyerinas, Sun-Mi Park, Noam Shomron, et al.
Journal for Immunotherapy of Cancer|March 13, 2023
Metabolic reprogramming via an engineered PGC-1α improves human chimeric antigen receptor T-cell therapy against solid tumorsKonstantinos Lontos, Yiyang Wang, Supriya K Joshi, et al.
Molecular Cell|August 3, 2005
Phosphorylation of FADD at serine 194 by CKIalpha regulates its nonapoptotic activitiesElizabeth C Alappat, Christine Feig, Benjamin Boyerinas, et al.
Pageof 1